APPLICATION
ANDA065071
TYPE
ANDA
ORIGINAL APPROVAL
2002-11-20
LATEST ACTION
2020-06-08
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
CEFOTAXIMEDiscontinued
CEFOTAXIME SODIUM EQ 10GM BASE/VIAL · INJECTABLE · INJECTION
Approval history
2020-06-08Labeling · Supplement 14 · standardAP
2020-06-08Labeling · Supplement 12 · standardAP
2020-06-08Labeling · Supplement 11 · standardAP
2002-11-20OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.